Avouac Jérôme, Huscher Dörte, Furst Daniel E, Opitz Christian F, Distler Oliver, Allanore Yannick, Allanore Yannick   Expert consensus for performing right heart catheterisation for suspected pulmonary arterial hypertension in systemic sclerosis: a Delphi consensus study with cluster analysis Annals of the rheumatic diseases, 2013; .

Furst Daniel E, Fernandes Ancilla W, Iorga Serban R, Greth Warren, Bancroft Tim   Annual medical costs and healthcare resource use in patients with systemic sclerosis in an insured population The Journal of rheumatology, 2012; 39(12): 2303-9.

Jawaheer Damini, Messing Susan, Reed George, Ranganath Veena K, Kremer Joel M, Louie James S, Khanna Dinesh, Greenberg Jeffrey D, Furst Daniel E   Significance of sex in achieving sustained remission in the consortium of rheumatology researchers of North America cohort of rheumatoid arthritis patients Arthritis care & research, 2012; 64(12): 1811-8.

Tarp Simon, Bartels Else M, Bliddal Henning, Furst Daniel E, Boers Maarten, Danneskiold-Samsøe Bente, Rasmussen Mette, Christensen Robin   Effect of nonsteroidal antiinflammatory drugs on the C-reactive protein level in rheumatoid arthritis: a meta-analysis of randomized controlled trials Arthritis and rheumatism, 2012; 64(11): 3511-21.

Bartlett Susan J, Hewlett Sarah, Bingham Clifton O, Woodworth Thasia G, Alten Rieke, Pohl Christoph, Choy Ernest H, Sanderson Tessa, Boonen Annelies, Bykerk Vivian, Leong Amye L, Strand Vibeke, Furst Daniel E, Christensen Robin, Christensen Robin   Identifying core domains to assess flare in rheumatoid arthritis: an OMERACT international patient and provider combined Delphi consensus Annals of the rheumatic diseases, 2012; 71(11): 1855-60.

van Vollenhoven Ronald F, Emery Paul, Bingham Clifton O, Keystone Edward C, Fleischmann Roy M, Furst Daniel E, Tyson Nicola, Collinson Neil, Lehane Patricia B   Long-term safety of rituximab in rheumatoid arthritis: 9.5-year follow-up of the global clinical trial programme with a focus on adverse events of interest in RA patients Annals of the rheumatic diseases, 2012; 39(12): .

Khanna Dinesh, Fitzgerald John D, Khanna Puja P, Bae Sangmee, Singh Manjit K, Neogi Tuhina, Pillinger Michael H, Merill Joan, Lee Susan, Prakash Shraddha, Kaldas Marian, Gogia Maneesh, Perez-Ruiz Fernando, Taylor Will, Lioté Frédéric, Choi Hyon, Singh Jasvinder A, Dalbeth Nicola, Kaplan Sanford, Niyyar Vandana, Jones Danielle, Yarows Steven A, Roessler Blake, Kerr Gail, King Charles, Levy Gerald, Furst Daniel E, Edwards N Lawrence, Mandell Brian, Schumacher H Ralph, Robbins Mark, Wenger Neil, Terkeltaub Robert, Terkeltaub Robert   2012 American College of Rheumatology guidelines for management of gout. Part 1: systematic nonpharmacologic and pharmacologic therapeutic approaches to hyperuricemia Arthritis care & research, 2012; 64(10): 1431-46.

Khanna Dinesh, Khanna Puja P, Fitzgerald John D, Singh Manjit K, Bae Sangmee, Neogi Tuhina, Pillinger Michael H, Merill Joan, Lee Susan, Prakash Shraddha, Kaldas Marian, Gogia Maneesh, Perez-Ruiz Fernando, Taylor Will, Lioté Frédéric, Choi Hyon, Singh Jasvinder A, Dalbeth Nicola, Kaplan Sanford, Niyyar Vandana, Jones Danielle, Yarows Steven A, Roessler Blake, Kerr Gail, King Charles, Levy Gerald, Furst Daniel E, Edwards N Lawrence, Mandell Brian, Schumacher H Ralph, Robbins Mark, Wenger Neil, Terkeltaub Robert, Terkeltaub Robert   2012 American College of Rheumatology guidelines for management of gout. Part 2: therapy and antiinflammatory prophylaxis of acute gouty arthritis Arthritis care & research, 2012; 64(10): 1447-61.

Singh Jasvinder A, Furst Daniel, Saag Kenneth G   2012 update of the 2008 ACR recommendations for the use of disease-modifying antirheumatic drugs and biologic agents in the treatment of RA: Reply to letter by Graudal et al Arthritis care & research, 2012; 64(11): .

Furst Daniel E, Amato Anthony A, Iorga Serban R, Bancroft Tim, Fernandes Ancilla W   Medical costs and health-care resource use in patients with inflammatory myopathies in an insured population Muscle & nerve, 2012; 46(4): 496-505.

Amarilyo Gil, Woo Jennifer M P, Furst Daniel E, Hoffman Olivia L, Eyal Rotem, Piao Cijing, Parker Douglass S, McCurdy Deborah K   Publication outcomes of abstracts presented at the ACR/ARHP annual scientific meeting Arthritis care & research, 2012; 64(11): .

Avouac Jérôme, Clements Philip J, Khanna Dinesh, Furst Daniel E, Allanore Yannick   Articular involvement in systemic sclerosis Rheumatology (Oxford, England), 2012; 51(8): 1347-56.

Bae Sangmee, Saggar Rajeev, Bolster Marcy B, Chung Lorinda, Csuka Mary Ellen, Derk Chris, Domsic Robyn, Fischer Aryeh, Frech Tracy, Goldberg Avram, Hinchcliff Monique, Hsu Vivien, Hummers Laura, Schiopu Elena, Mayes Maureen D, McLaughlin Vallerie, Molitor Jerry, Naz Nausheen, Furst Daniel E, Maranian Paul, Steen Virginia, Khanna Dinesh   Baseline characteristics and follow-up in patients with normal haemodynamics versus borderline mean pulmonary arterial pressure in systemic sclerosis: results from the PHAROS registry Annals of the rheumatic diseases, 2012; 71(8): 1335-42.

Massardo Loreto, Pons-Estel Bernardo A, Wojdyla Daniel, Cardiel Mario H, Galarza-Maldonado Claudio M, Sacnun Mónica P, Soriano Enrique R, Laurindo Ieda M, Acevedo-Vásquez Eduardo M, Caballero-Uribe Carlo V, Padilla Oslando, Guibert-Toledano Zoila M, da Mota Licia M, Montufar Rubén A, Lino-Pérez Leticia, Díaz-Coto José F, Achurra-Castillo Angel F, Hernández Jaime A, Esteva-Spinetti María H, Ramírez Luis A, Pineda Carlos, Furst Daniel E   Early rheumatoid arthritis in Latin America: low socioeconomic status related to high disease activity at baseline Arthritis care & research, 2012; 64(8): 1135-43.

Kim Paul S, Ho Gerald Y, Prete Pamela E, Furst Daniel E   Safety and efficacy of abatacept in eight rheumatoid arthritis patients with chronic hepatitis B Arthritis care & research, 2012; 64(8): 1265-8.

Morgacheva Olga, Furst Daniel E   Women are from venus, men are from Mars: do gender differences also apply to rheumatoid arthritis activity and treatment responses? Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases, 2012; 18(5): 259-60.

Greenberg Jeffrey D, Reed George, Decktor Dennis, Harrold Leslie, Furst Daniel, Gibofsky Allan, Dehoratius Ralph, Kishimoto Mitsumasa, Kremer Joel M, Kremer Joel M   A comparative effectiveness study of adalimumab, etanercept and infliximab in biologically naive and switched rheumatoid arthritis patients: results from the US CORRONA registry Annals of the rheumatic diseases, 2012; 71(7): 1134-42.

Sharif Roozbeh, Mayes Maureen D, Tan Filemon K, Gorlova Olga Y, Hummers Laura Kathleen, Shah Ami A, Furst Daniel E, Khanna Dinesh, Martin Javier, Bossini-Castillo Lara, Gonzalez Emilio B, Ying Jun, Draeger Hilda Torres, Agarwal Sandeep K, Reveille John D, Arnett Frank C, Wigley Fredrick M, Assassi Shervin   IRF5 polymorphism predicts prognosis in patients with systemic sclerosis Annals of the rheumatic diseases, 2012; 71(7): 1197-202.

van der Heijde Désirée, Keystone Edward C, Curtis Jeffrey R, Landewé Robert B, Schiff Michael H, Khanna Dinesh, Kvien Tore K, Ionescu Lucian, Gervitz Leon M, Davies Owen R, Luijtens Kristel, Furst Daniel E   Timing and magnitude of initial change in disease activity score 28 predicts the likelihood of achieving low disease activity at 1 year in rheumatoid arthritis patients treated with certolizumab pegol: a post-hoc analysis of the RAPID 1 trial The Journal of rheumatology, 2012; 39(7): 1326-33.

Clements Philip J, Allanore Yannick, Khanna Dinesh, Singh Minjit, Furst Daniel E   Arthritis in systemic sclerosis: systematic review of the literature and suggestions for the performance of future clinical trials in systemic sclerosis arthritis Seminars in arthritis and rheumatism, 2012; 41(6): 801-14.

Agrawal Harsh, Hay M Cameron, Volkmann Elizabeth R, Maranian Paul, Khanna Dinesh, Furst Daniel E   Satisfaction and access to clinical care in a rheumatology clinic at a large urban medical center Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases, 2012; 18(4): 209-11.

Singh Jasvinder A, Furst Daniel E, Bharat Aseem, Curtis Jeffrey R, Kavanaugh Arthur F, Kremer Joel M, Moreland Larry W, O'Dell James, Winthrop Kevin L, Beukelman Timothy, Bridges S Louis, Chatham W Winn, Paulus Harold E, Suarez-Almazor Maria, Bombardier Claire, Dougados Maxime, Khanna Dinesh, King Charles M, Leong Amye L, Matteson Eric L, Schousboe John T, Moynihan Eileen, Kolba Karen S, Jain Archana, Volkmann Elizabeth R, Agrawal Harsh, Bae Sangmee, Mudano Amy S, Patkar Nivedita M, Saag Kenneth G   2012 update of the 2008 American College of Rheumatology recommendations for the use of disease-modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis Arthritis care & research, 2012; 64(5): 625-39.

Furst Daniel E, Amato Anthony A, Iorga ?erban R, Gajria Kavita, Fernandes Ancilla W   Epidemiology of adult idiopathic inflammatory myopathies in a U.S. managed care plan Muscle & nerve, 2012; 45(5): 676-83.

Furst Daniel E, Fernandes Ancilla W, Iorga Serban R, Greth Warren, Bancroft Tim   Epidemiology of systemic sclerosis in a large US managed care population The Journal of rheumatology, 2012; 39(4): 784-6.

Furst Daniel E, Mandell Brian   Perspectives in Rheumatoid Abstracts from 2011 meeting selected proceedings of the 4(th) Annual Perspectives in Rheumatic Diseases 2011 Seminars in arthritis and rheumatism, 2012; 41(5): 737-9.

Chung Lorinda, Denton Christopher P, Distler Oliver, Furst Daniel E, Khanna Dinesh, Merkel Peter A, Merkel Peter A   Clinical trial design in scleroderma: where are we and where do we go next? Clinical and experimental rheumatology, 2012; 30(2 Suppl 71): S97-102.

Fransen Jaap, Johnson Sindhu R, van den Hoogen Frank, Baron Murray, Allanore Yannick, Carreira Patricia E, Czirják László, Denton Christopher P, Distler Oliver, Furst Daniel E, Gabrielli Armando, Herrick Ariane, Inanc Murat, Kahaleh Bashar, Kowal-Bielecka Otylia, Medsger Thomas A, Mueller-Ladner Ulf, Riemekasten Gabriela, Sierakowski Stanislaw, Valentini Gabriele, Veale Doug, Vonk Madelon C, Walker Ulrich, Chung Lorinda, Clements Philip J, Collier David H, Csuka Mary E, Jimenez Sergio, Merkel Peter A, Seibold James R, Silver Richard, Steen Virginia, Tyndall Alan, Matucci-Cerinic Marco, Pope Janet E, Khanna Dinesh   Items for developing revised classification criteria in systemic sclerosis: Results of a consensus exercise Arthritis care & research, 2012; 64(3): 351-7.

Thombs Brett D, Jewett Lisa R, Assassi Shervin, Baron Murray, Bartlett Susan J, Maia Angela Costa, El-Baalbaki Ghassan, Furst Daniel E, Gottesman Karen, Haythornthwaite Jennifer A, Hudson Marie, Impens Ann, Korner Annett, Leite Catarina, Mayes Maureen D, Malcarne Vanessa L, Motivala Sarosh J, Mouthon Luc, Nielson Warren R, Plante Diane, Poiraudeau Serge, Poole Janet L, Pope Janet, Sauve Maureen, Steele Russell J, Suarez-Almazor Maria E, Taillefer Suzanne, van den Ende Cornelia H, Arthurs Erin, Bassel Marielle, Delisle Vanessa, Milette Katherine, Leavens Allison, Razykov Ilya, Khanna Dinesh   New directions for patient-centred care in scleroderma: the Scleroderma Patient-centred Intervention Network (SPIN) Clinical and experimental rheumatology, 2012; 30(2 Suppl 71): S23-9.

Harrold Leslie R, Harrington J Timothy, Curtis Jeffrey R, Furst Daniel E, Bentley Mary Jane, Shan Ying, Reed George, Kremer Joel, Greenberg Jeffrey D   Prescribing practices in a US cohort of rheumatoid arthritis patients before and after publication of the American College of Rheumatology treatment recommendations Arthritis and rheumatism, 2012; 64(3): 630-8.

Singh Manjit K, Clements Philip J, Furst Daniel E, Maranian Paul, Khanna Dinesh   Work productivity in scleroderma: analysis from the University of California, Los Angeles scleroderma quality of life study Arthritis care & research, 2012; 64(2): 176-83.

Khanna Dinesh, Maranian Paul, Rothrock Nan, Cella David, Gershon Richard, Khanna Puja P, Spiegel Brennan, Furst Daniel E, Clements Phil J, Bechtel Amber, Hays Ron D   Feasibility and construct validity of PROMIS and "legacy" instruments in an academic scleroderma clinic Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research, 2012; 15(1): 128-34.

Sullivan Keith M, Wigley Frederick M, Denton Christopher P, van Laar Jacob M, Furst Daniel E   Haemopoietic stem-cell transplantation for systemic sclerosis Lancet, 2012; 379(9812): 219; author reply 219-20.

Divekar Anagha A, Khanna Dinesh, Abtin Fereidoun, Maranian Paul, Saggar Rajeev, Saggar Rajan, Furst Daniel E, Singh Ram Raj   Treatment with imatinib results in reduced IL-4-producing T cells, but increased CD4(+) T cells in the broncho-alveolar lavage of patients with systemic sclerosis Clinical immunology (Orlando, Fla.), 2011; 141(3): 293-303.

Khanna Dinesh, Saggar Rajeev, Mayes Maureen D, Abtin Fereidoun, Clements Philip J, Maranian Paul, Assassi Shervin, Saggar Rajan, Singh Ram R, Furst Daniel E   A one-year, phase I/IIa, open-label pilot trial of imatinib mesylate in the treatment of systemic sclerosis-associated active interstitial lung disease Arthritis and rheumatism, 2011; 63(11): 3540-6.

Kowal-Bielecka Otylia, Avouac Jerome, Pittrow David, Huscher Doerte, Behrens Frank, Denton Christopher P, Foeldvari Ivan, Humbert Marc, Matucci-Cerinic Marco, Nash Peter, Opitz Christian F, Rubin Lewis J, Seibold James R, Strand Vibeke, Furst Daniel E, Distler Oliver, Distler Oliver   Analysis of the validation status of quality of life and functional disability measures in pulmonary arterial hypertension related to systemic sclerosis: results of a systematic literature analysis by the Expert Panel on Outcomes Measures in Pulmonary Arterial Hypertension related to Systemic Sclerosis (EPOSS) The Journal of rheumatology, 2011; 38(11): 2419-27.

Khanna Dinesh, Tseng Chi-Hong, Farmani Niloofar, Steen Virginia, Furst Daniel E, Clements Philip J, Roth Michael D, Goldin Jonathan, Elashoff Robert, Seibold James R, Saggar Rajeev, Tashkin Donald P   Clinical course of lung physiology in patients with scleroderma and interstitial lung disease: analysis of the Scleroderma Lung Study Placebo Group Arthritis and rheumatism, 2011; 63(10): 3078-85.

Khanna Dinesh, Furst Daniel E, Maranian Paul, Seibold James R, Impens Ann, Mayes Maureen D, Clements Philip J, Getzug Terri, Hays Ron D   Minimally important differences of the UCLA Scleroderma Clinical Trial Consortium Gastrointestinal Tract Instrument The Journal of rheumatology, 2011; 38(9): 1920-4.

Roth Michael D, Tseng Chi-Hong, Clements Philip J, Furst Daniel E, Tashkin Donald P, Goldin Jonathan G, Khanna Dinesh, Kleerup Eric C, Li Ning, Elashoff David, Elashoff Robert M, Elashoff Robert M   Predicting treatment outcomes and responder subsets in scleroderma-related interstitial lung disease Arthritis and rheumatism, 2011; 63(9): 2797-808.

Sharif Roozbeh, Fritzler Marvin J, Mayes Maureen D, Gonzalez Emilio B, McNearney Terry A, Draeger Hilda, Baron Murray, Baron Murray, Furst Daniel E, Khanna Dinesh K, del Junco Deborah J, Molitor Jerry A, Schiopu Elena, Phillips Kristine, Seibold James R, Silver Richard M, Simms Robert W, Simms Robert W, Perry Marilyn, Rojo Carlos, Charles Julio, Zhou Xiaodong, Agarwal Sandeep K, Reveille John D, Assassi Shervin, Arnett Frank C   Anti-fibrillarin antibody in African American patients with systemic sclerosis: immunogenetics, clinical features, and survival analysis The Journal of rheumatology, 2011; 38(8): 1622-30.

Alten Rieke, Pohl Christof, Choy Ernest H, Christensen Robin, Furst Daniel E, Hewlett Sarah E, Leong Amye, May James E, Sanderson Tessa C, Strand Vibeke, Woodworth Thasia G, Bingham Clifton O, Bingham Clifton O   Developing a construct to evaluate flares in rheumatoid arthritis: a conceptual report of the OMERACT RA Flare Definition Working Group The Journal of rheumatology, 2011; 38(8): 1745-50.

Bingham Clifton O, Alten Rieke, Bartlett Susan J, Bykerk Vivian P, Brooks Peter M, Choy Ernest, Christensen Robin, Furst Daniel E, Hewlett Sarah E, Leong Amye, May James E, Montie Pam, Pohl Christof, Sanderson Tessa C, Strand Vibeke, Woodworth Thasia G, Woodworth Thasia G   Identifying preliminary domains to detect and measure rheumatoid arthritis flares: report of the OMERACT 10 RA Flare Workshop The Journal of rheumatology, 2011; 38(8): 1751-8.

Terkeltaub Robert A, Furst Daniel E, Digiacinto Jennifer L, Kook Karin A, Davis Matthew W   Novel evidence-based colchicine dose-reduction algorithm to predict and prevent colchicine toxicity in the presence of cytochrome P450 3A4/P-glycoprotein inhibitors Arthritis and rheumatism, 2011; 63(8): 2226-37.

Kirwan John R, Boonen Annelies, Harrison Mark J, Hewlett Sarah E, Wells George A, Singh Jasvinder A, Furst Daniel E, Dworkin Robert H   OMERACT 10 Patient Perspective Virtual Campus: valuing health; measuring outcomes in rheumatoid arthritis fatigue, RA sleep, arthroplasty, and systemic sclerosis; and clinical significance of changes in health The Journal of rheumatology, 2011; 38(8): 1728-34.

Ozturk Mehmet Akif, Kanbay Mehmet, Kasapoglu Benan, Onat Ahmet Mesut, Guz Galip, Furst Daniel E, Ben-Chetrit Eldad   Therapeutic approach to familial Mediterranean fever: a review update Clinical and experimental rheumatology, 2011; 29(4 Suppl 67): S77-86.

Frech Tracy, Hays Ron D, Maranian Paul, Clements Philip J, Furst Daniel E, Khanna Dinesh   Prevalence and correlates of sleep disturbance in systemic sclerosis--results from the UCLA scleroderma quality of life study Rheumatology (Oxford, England), 2011; 50(7): 1280-7.

Denton Christopher P, Avouac Jerome, Behrens Frank, Furst Daniel E, Foeldvari Ivan, Humbert Marc, Huscher Doerte, Kowal-Bielecka Otylia, Matucci-Cerinic Marco, Nash Peter, Opitz Christian F, Pittrow David, Rubin Lewis J, Seibold James R, Distler Oliver   Systemic sclerosis-associated pulmonary hypertension: why disease-specific composite endpoints are needed Arthritis research & therapy, 2011; 13(3): 114.

Furst Daniel E, Venkatraman Manorama M, McGann Mary, Manohar P Ram, Booth-LaForce Cathryn, Sarin Reshmi, Sekar P G, Raveendran K G, Mahapatra Anita, Gopinath Jidesh, Kumar P R Krishna   Double-blind, randomized, controlled, pilot study comparing classic ayurvedic medicine, methotrexate, and their combination in rheumatoid arthritis Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases, 2011; 17(4): 185-92.

Furst Daniel E, Pangan Aileen L, Harrold Leslie R, Chang Hong, Reed George, Kremer Joel M, Greenberg Jeffrey D   Greater likelihood of remission in rheumatoid arthritis patients treated earlier in the disease course: results from the Consortium of Rheumatology Researchers of North America registry Arthritis care & research, 2011; 63(6): 856-64.

Keystone Edward C, Curtis Jeffrey R, Fleischmann Roy M, Furst Daniel E, Khanna Dinesh, Smolen Josef S, Mease Philip J, Schiff Michael H, Coteur Geoffroy, Davies Owen, Combe Bernard   Rapid improvement in the signs and symptoms of rheumatoid arthritis following certolizumab pegol treatment predicts better longterm outcomes: post-hoc analysis of a randomized controlled trial The Journal of rheumatology, 2011; 38(6): 990-6.

Furst Daniel E, Tseng Chi-Hong, Clements Philip J, Strange Charlie, Tashkin Donald P, Roth Michael D, Khanna Dinesh, Li Ning, Elashoff Robert, Schraufnagel Dean E, Schraufnagel Dean E   Adverse events during the Scleroderma Lung Study The American journal of medicine, 2011; 124(5): 459-67.

Au Karen, Reed George, Curtis Jeffrey R, Kremer Joel M, Greenberg Jeffrey D, Strand Vibeke, Furst Daniel E, Furst Daniel E   High disease activity is associated with an increased risk of infection in patients with rheumatoid arthritis Annals of the rheumatic diseases, 2011; 70(5): 785-91.

Felson David T, Smolen Josef S, Wells George, Zhang Bin, van Tuyl Lilian H D, Funovits Julia, Aletaha Daniel, Allaart Cornelia F, Bathon Joan, Bombardieri Stefano, Brooks Peter, Brown Andrew, Matucci-Cerinic Marco, Choi Hyon, Combe Bernard, de Wit Maarten, Dougados Maxime, Emery Paul, Furst Daniel, Gomez-Reino Juan, Hawker Gillian, Keystone Edward, Khanna Dinesh, Kirwan John, Kvien Tore K, Landewé Robert, Listing Joachim, Michaud Kaleb, Martin-Mola Emilio, Montie Pamela, Pincus Theodore, Richards Pamela, Siegel Jeffrey N, Simon Lee S, Sokka Tuulikki, Strand Vibeke, Tugwell Peter, Tyndall Alan, van der Heijde Desirée, Verstappen Suzan, White Barbara, Wolfe Frederick, Zink Angela, Boers Maarten, Boers Maarten, Boers Maarten   American College of Rheumatology/European League Against Rheumatism provisional definition of remission in rheumatoid arthritis for clinical trials Arthritis and rheumatism, 2011; 63(3): 573-86.

Felson David T, Smolen Josef S, Wells George, Zhang Bin, van Tuyl Lilian H D, Funovits Julia, Aletaha Daniel, Allaart Cornelia F, Bathon Joan, Bombardieri Stefano, Brooks Peter, Brown Andrew, Matucci-Cerinic Marco, Choi Hyon, Combe Bernard, de Wit Maarten, Dougados Maxime, Emery Paul, Furst Daniel, Gomez-Reino Juan, Hawker Gillian, Keystone Edward, Khanna Dinesh, Kirwan John, Kvien Tore K, Landewé Robert, Listing Joachim, Michaud Kaleb, Martin-Mola Emilio, Montie Pamela, Pincus Theodore, Richards Pamela, Siegel Jeffrey N, Simon Lee S, Sokka Tuulikki, Strand Vibeke, Tugwell Peter, Tyndall Alan, van der Heijde Desirée, Verstappen Suzan, White Barbara, Wolfe Frederick, Zink Angela, Boers Maarten   American College of Rheumatology/European League against Rheumatism provisional definition of remission in rheumatoid arthritis for clinical trials Annals of the rheumatic diseases, 2011; 70(3): 404-13.

Khanna Dinesh, Kowal-Bielecka Otylia, Khanna Puja P, Lapinska Anna, Asch Steven M, Wenger Neil, Brown Kevin K, Clements Philip J, Getzug Terry, Mayes Maureen D, Medsger Thomas A, Oudiz Ronald, Simms Robert, Steen Virginia, Maranian Paul, Furst Daniel E   Quality indicator set for systemic sclerosis Clinical and experimental rheumatology, 2011; 29(2 Suppl 65): S33-9.

Bodukam Vijay, Hays Ron D, Maranian Paul, Furst Daniel E, Seibold James R, Impens Ann, Mayes Maureen D, Clements Philip J, Khanna Dinesh   Association of gastrointestinal involvement and depressive symptoms in patients with systemic sclerosis Rheumatology (Oxford, England), 2011; 50(2): 330-4.

Nashid Mahsa, Khanna Puja P, Furst Daniel E, Clements Philip J, Maranian Paul, Seibold James, Postlethwaite Arnold E, Louie James S, Mayes Maureen D, Agrawal Harsh, Khanna Dinesh, Khanna Dinesh   Gender and ethnicity differences in patients with diffuse systemic sclerosis--analysis from three large randomized clinical trials Rheumatology (Oxford, England), 2011; 50(2): 335-42.

Furst Daniel E, Venkatraman Manorama M, Krishna Swamy B G, McGann Mary, Booth-Laforce Cathryn, Ram Manohar P, Sarin Reshmi, Mahapatra Anita, Krishna Kumar P R   Well controlled, double-blind, placebo-controlled trials of classical Ayurvedic treatment are possible in rheumatoid arthritis Annals of the rheumatic diseases, 2011; 70(2): 392-3.

Matucci-Cerinic Marco, Denton Christopher P, Furst Daniel E, Mayes Maureen D, Hsu Vivien M, Carpentier Patrick, Wigley Fredrick M, Black Carol M, Fessler Barri J, Merkel Peter A, Pope Janet E, Sweiss Nadera J, Doyle Mittie K, Hellmich Bernhard, Medsger Thomas A, Morganti Adele, Kramer Fabrice, Korn Joseph H, Seibold James R   Bosentan treatment of digital ulcers related to systemic sclerosis: results from the RAPIDS-2 randomised, double-blind, placebo-controlled trial Annals of the rheumatic diseases, 2011; 70(1): 32-8.

Au Karen, Mayes Maureen D, Maranian Paul, Clements Philip J, Khanna Dinesh, Steen Virginia D, Tashkin Donald, Roth Michael D, Elashoff Robert, Furst Daniel E   Course of dermal ulcers and musculoskeletal involvement in systemic sclerosis patients in the scleroderma lung study Arthritis care & research, 2010; 62(12): 1772-8.

Saggar Rajeev, Khanna Dinesh, Furst Daniel E, Shapiro Shelley, Maranian Paul, Belperio John A, Chauhan Neeraj, Clements Philip, Gorn Alan, Weigt S Sam, Ross David, Lynch Joseph P, Saggar Rajan   Exercise-induced pulmonary hypertension associated with systemic sclerosis: four distinct entities Arthritis and rheumatism, 2010; 62(12): 3741-50.

Grossman Jennifer M, Gordon Rebecca, Ranganath Veena K, Deal Chad, Caplan Liron, Chen Weiling, Curtis Jeffrey R, Furst Daniel E, McMahon Maureen, Patkar Nivedita M, Volkmann Elizabeth, Saag Kenneth G   American College of Rheumatology 2010 recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis Arthritis care & research, 2010; 62(11): 1515-26.

Tan Wenfeng, Wu Hui, Zhao Jian, Derber Lezlie A, Lee David M, Shadick Nancy A, Conn Doyt L, Smith Edwin A, Gersuk Vivian H, Nepom Gerald T, Moreland Larry W, Furst Daniel E, Thompson Susan D, Jonas Beth L, Holers V Michael, Glass David N, Chen Pojen P, Bridges S Louis, Weinblatt Michael E, Paulus Harold E, Tsao Betty P   A functional RANKL polymorphism associated with younger age at onset of rheumatoid arthritis Arthritis and rheumatism, 2010; 62(10): 2864-75.

Sokolove Jeremy, Strand Vibeke, Greenberg Jeffrey D, Curtis Jeffrey R, Kavanaugh Arthur, Kremer Joel M, Anofrei Alina, Reed George, Calabrese Leonard, Hooper Michele, Baumgartner Scott, Furst Daniel E, Furst Daniel E   Risk of elevated liver enzymes associated with TNF inhibitor utilisation in patients with rheumatoid arthritis Annals of the rheumatic diseases, 2010; 69(9): 1612-7.

Sawitzke Allen D, Shi Helen, Finco Martha F, Dunlop Dorothy D, Harris Crystal L, Singer Nora G, Bradley John D, Silver David, Jackson Christopher G, Lane Nancy E, Oddis Chester V, Wolfe Fred, Lisse Jeffrey, Furst Daniel E, Bingham Clifton O, Reda Domenic J, Moskowitz Roland W, Williams H James, Clegg Daniel O   Clinical efficacy and safety of glucosamine, chondroitin sulphate, their combination, celecoxib or placebo taken to treat osteoarthritis of the knee: 2-year results from GAIT Annals of the rheumatic diseases, 2010; 69(8): 1459-64.

Furst Daniel E   Development of TNF inhibitor therapies for the treatment of rheumatoid arthritis Clinical and experimental rheumatology, 2010; 28(3 Suppl 59): S5-12.

Avouac Jérôme, Kowal-Bielecka Otylia, Pittrow David, Huscher Doerte, Behrens Frank, Denton Christopher P, Foeldvari Ivan, Humbert Marc, Matucci-Cerinic Marco, Nash Peter, Opitz Christian F, Rubin Lewis J, Seibold James R, Distler Oliver, Furst Daniel E, Furst Daniel E   Validation of the 6 min walk test according to the OMERACT filter: a systematic literature review by the EPOSS-OMERACT group Annals of the rheumatic diseases, 2010; 69(7): 1360-3.

Khanna Dinesh, Seibold James R, Wells Athol, Distler Oliver, Allanore Yannick, Denton Chris, Furst Daniel E   Systemic Sclerosis-Associated Interstitial Lung Disease: Lessons from Clinical Trials, Outcome Measures, and Future Study Design Current rheumatology reviews, 2010; 6(2): 138-144.

Khanna Puja P, Furst Daniel E, Clements Philip J, Maranian Paul, Indulkar Lilavati, Khanna Dinesh, Khanna Dinesh   Tendon friction rubs in early diffuse systemic sclerosis: prevalence, characteristics and longitudinal changes in a randomized controlled trial Rheumatology (Oxford, England), 2010; 49(5): 955-9.

Terkeltaub Robert A, Furst Daniel E, Bennett Katherine, Kook Karin A, Crockett R S, Davis Matthew W   High versus low dosing of oral colchicine for early acute gout flare: Twenty-four-hour outcome of the first multicenter, randomized, double-blind, placebo-controlled, parallel-group, dose-comparison colchicine study Arthritis and rheumatism, 2010; 62(4): 1060-8.

Huscher Doerte, Pittrow David, Distler Oliver, Denton Christopher P, Foeldvari Ivan, Humbert Marc, Matucci-Cerinic Marco, Kowal-Bielecka Otylia, Avouac Jerome, Behrens Frank, Nash Peter, Opitz Christian F, Rubin Lewis J, Seibold James R, Strand Vibeke, Furst Daniel E, Furst Daniel E   Interactions between rheumatologists and cardio-/pulmonologists in the assessment and use of outcome measures in pulmonary arterial hypertension related to systemic sclerosis Clinical and experimental rheumatology, 2010; 28(2 Suppl 58): S47-52.

Khanna Dinesh, Brown Kevin K, Clements Philip J, Elashoff Robert, Furst Daniel E, Goldin Jonathan, Seibold James R, Silver Richard M, Tashkin Donald P, Wells Athol U   Systemic sclerosis-associated interstitial lung disease-proposed recommendations for future randomized clinical trials Clinical and experimental rheumatology, 2010; 28(2 Suppl 58): S55-62.

Furst Daniel E   The risk of infections with biologic therapies for rheumatoid arthritis Seminars in arthritis and rheumatism, 2010; 39(5): 327-46.

Hudson Marie, Baron Murray, Lo Ernest, Weinfeld Joanna, Furst Daniel E, Khanna Dinesh   An International, Web-Based, Prospective Cohort Study to Determine Whether the Use of ACE Inhibitors prior to the Onset of Scleroderma Renal Crisis Is Associated with Worse Outcomes-Methodology and Preliminary Results International journal of rheumatology, 2010; 2010(1): .

Storage Steven S, Agrawal Harsh, Furst Daniel E   Description of the efficacy and safety of three new biologics in the treatment of rheumatoid arthritis The Korean journal of internal medicine, 2010; 25(1): 1-17.

Weng Haoling H, Ranganath Veena K, Khanna Dinesh, Oh Myungshin, Furst Daniel E, Park Grace S, Elashoff David A, Sharp John T, Gold Richard H, Peter James B, Paulus Harold E, Paulus Harold E   Equivalent responses to disease-modifying antirheumatic drugs initiated at any time during the first 15 months after symptom onset in patients with seropositive rheumatoid arthritis The Journal of rheumatology, 2010; 37(3): 550-7.

van Vollenhoven Ronald F, Emery Paul, Bingham Clifton O, Keystone Edward C, Fleischmann Roy, Furst Daniel E, Macey Katherine, Sweetser Marianne, Kelman Ariella, Rao Ravi   Longterm safety of patients receiving rituximab in rheumatoid arthritis clinical trials The Journal of rheumatology, 2010; 37(3): 558-67.

Kowal-Bielecka Otylia, Avouac Jerome, Pittrow David, Huscher Doerte, Behrens Frank, Denton Christopher P, Foeldvari Ivan, Humbert Marc, Matucci-Cerinic Marco, Nash Peter, Opitz Christian F, Rubin Lewis J, Seibold James R, Strand Vibeke, Furst Daniel E, Distler Oliver, Distler Oliver   Echocardiography as an outcome measure in scleroderma-related pulmonary arterial hypertension: a systematic literature analysis by the EPOSS group The Journal of rheumatology, 2010; 37(1): 105-15.

Khanna Dinesh, Tseng Chi-Hong, Furst Daniel E, Clements Philip J, Elashoff Robert, Roth Michael, Elashoff David, Tashkin Donald P, Tashkin Donald P   Minimally important differences in the Mahler's Transition Dyspnoea Index in a large randomized controlled trial--results from the Scleroderma Lung Study Rheumatology (Oxford, England), 2009; 48(12): 1537-40.

Su Tien-I Karleen, Khanna Dinesh, Furst Daniel E, Danovitch Gabriel, Burger Christina, Maranian Paul, Clements Philip J   Rapamycin versus methotrexate in early diffuse systemic sclerosis: results from a randomized, single-blind pilot study Arthritis and rheumatism, 2009; 60(12): 3821-30.

Goldin Jonathan, Elashoff Robert, Kim Hyun J, Yan Xaiohong, Lynch David, Strollo Diane, Roth Michael D, Clements Philip, Furst Daniel E, Khanna Dinesh, Vasunilashorn Srainnapha, Li Gang, Tashkin Donald P   Treatment of scleroderma-interstitial lung disease with cyclophosphamide is associated with less progressive fibrosis on serial thoracic high-resolution CT scan than placebo: findings from the scleroderma lung study Chest, 2009; 136(5): 1333-40.

Merz Erin L, Malcarne Vanessa L, Hansdottir Ingunn, Furst Daniel E, Clements Philip J, Weisman Michael H   A longitudinal analysis of humor coping and quality of life in systemic sclerosis Psychology, health & medicine, 2009; 14(5): 553-66.

Charles-Schoeman Christina, Watanabe Junji, Lee Yuen Yin, Furst Daniel E, Amjadi Sogol, Elashoff David, Park Grace, McMahon Maureen, Paulus Harold E, Fogelman Alan M, Reddy Srinivasa T   Abnormal function of high-density lipoprotein is associated with poor disease control and an altered protein cargo in rheumatoid arthritis Arthritis and rheumatism, 2009; 60(10): 2870-9.

Bingham Clifton O, Pohl Christoph, Woodworth Thasia G, Hewlett Sarah E, May James E, Rahman Mahboob U, Witter James P, Furst Daniel E, Strand C Vibeke, Boers Maarten, Alten Rieke E   Developing a standardized definition for disease "flare" in rheumatoid arthritis (OMERACT 9 Special Interest Group) The Journal of rheumatology, 2009; 36(10): 2335-41.

Khanna Dinesh, Distler Oliver, Avouac Jerome, Behrens Frank, Clements Philip J, Denton Christopher, Foeldvari Ivan, Giannini Edward, Huscher Doerte, Kowal-Bielecka Otylia, Lovell Daniel, Matucci-Cerinic Marco, Mayes Maureen, Merkel Peter A, Nash Peter, Opitz Christian F, Pittrow David, Rubin Lewis, Seibold James R, Steen Virginia, Strand C Vibeke, Tugwell Peter S, Varga John, Zink Angela, Furst Daniel E, Furst Daniel E, Furst Daniel E   Measures of response in clinical trials of systemic sclerosis: the Combined Response Index for Systemic Sclerosis (CRISS) and Outcome Measures in Pulmonary Arterial Hypertension related to Systemic Sclerosis (EPOSS) The Journal of rheumatology, 2009; 36(10): 2356-61.

Khanna Dinesh, Hays Ron D, Maranian Paul, Seibold James R, Impens Ann, Mayes Maureen D, Clements Philip J, Getzug Terri, Fathi Nihal, Bechtel Amber, Furst Daniel E   Reliability and validity of the University of California, Los Angeles Scleroderma Clinical Trial Consortium Gastrointestinal Tract Instrument Arthritis and rheumatism, 2009; 61(9): 1257-63.

Kaldas Marian, Khanna Puja P, Furst Daniel E, Clements Philip J, Kee Wong Weng, Seibold James R, Postlethwaite Arnold E, Khanna Dinesh, Khanna Dinesh   Sensitivity to change of the modified Rodnan skin score in diffuse systemic sclerosis--assessment of individual body sites in two large randomized controlled trials Rheumatology (Oxford, England), 2009; 48(9): 1143-6.

Amjadi Sogol, Maranian Paul, Furst Daniel E, Clements Philip J, Wong Weng Kee, Postlethwaite Arnold E, Khanna Puja P, Khanna Dinesh, Khanna Dinesh   Course of the modified Rodnan skin thickness score in systemic sclerosis clinical trials: analysis of three large multicenter, double-blind, randomized controlled trials Arthritis and rheumatism, 2009; 60(8): 2490-8.

Furst Daniel E   Serum immunoglobulins and risk of infection: how low can you go? Seminars in arthritis and rheumatism, 2009; 39(1): 18-29.

Holmberg Leona A, Furst Daniel E, McSweeney Peter A, Nash Richard A   Thymoglobulin and cyclophosphamide as treatment for diffuse cutaneous systemic sclerosis The Journal of rheumatology, 2009; 36(8): 1839.

Malaviya Anand N, Kapoor Sanjiv, Garg Shriram, Rawat Roopa, Shankar Subramanian, Nagpal Savita, Khanna Dinesh, Furst Daniel E   Preventing tuberculosis flare in patients with inflammatory rheumatic diseases receiving tumor necrosis factor-alpha inhibitors in India -- An audit report The Journal of rheumatology, 2009; 36(7): 1414-20.

Hunter Aimee M, Leuchter Andrew F, Cook Ian A, Abrams Michelle, Siegman Barbara E, Furst Daniel E, Chappell Amy S   Brain functional changes and duloxetine treatment response in fibromyalgia: a pilot study Pain medicine (Malden, Mass.), 2009; 10(4): 730-8.

Amjadi Sogol S, Maranian Paul M, Paulus Harold E, Kaplan Robert M, Ranganath Veena K, Furst Daniel E, Khanna Puja P, Khanna Dinesh, Khanna Dinesh   Validating and assessing the sensitivity of the Health Assessment Questionnaire-Disability Index-derived Short Form-6D in patients with early aggressive rheumatoid arthritis The Journal of rheumatology, 2009; 36(6): 1150-7.

Au Karen, Khanna Dinesh, Clements Philip J, Furst Daniel E, Tashkin Donald P   Current concepts in disease-modifying therapy for systemic sclerosis-associated interstitial lung disease: lessons from clinical trials Current rheumatology reports, 2009; 11(2): 111-9.

Khanna Dinesh, Clements Philip J, Furst Daniel E, Korn Joseph H, Ellman Michael, Rothfield Naomi, Wigley Fredrick M, Moreland Larry W, Silver Richard, Kim Youn H, Steen Virginia D, Firestein Gary S, Kavanaugh Arthur F, Weisman Michael, Mayes Maureen D, Collier David, Csuka Mary E, Simms Robert, Merkel Peter A, Medsger Thomas A, Sanders Martin E, Maranian Paul, Seibold James R, Seibold James R   Recombinant human relaxin in the treatment of systemic sclerosis with diffuse cutaneous involvement: a randomized, double-blind, placebo-controlled trial Arthritis and rheumatism, 2009; 60(4): 1102-11.